纳米技术增强的高血压透皮贴片:综述。

IF 1.5 Q3 PERIPHERAL VASCULAR DISEASE
Nishant Yadav, Parveen Kumar, Thakur Gurjeet Singh, Sushma Devi
{"title":"纳米技术增强的高血压透皮贴片:综述。","authors":"Nishant Yadav, Parveen Kumar, Thakur Gurjeet Singh, Sushma Devi","doi":"10.2174/0115734021373953250416105243","DOIUrl":null,"url":null,"abstract":"<p><p>Transdermal Drug Delivery System (TDDS) is one of the controlled drug delivery sys-tems whose purpose is to deliver medication through the skin at a predetermined and regulated rate. Nanotechnology has enhanced the skin's absorption of lipophilic, low-molecular-weight med-icines with low-dose efficacy, making transdermal drug delivery systems a viable technique for treating various conditions. TDDS permits greater skin permeation of hydrophilic drugs, and sci-entists are studying macromolecules to improve disease treatment and vaccine development. While additional study is needed to determine nanocarrier safety, this approach could increase the usage of transdermal routes for administering hypertension medicines. As hypertension remains the most prevalent form of cardiovascular illness, we focus on how nanoparticles as skin delivery methods might be used to better treat this global problem. In addition, patients may not be willing to comply with traditional doses due to the greater frequency of drug administration necessary for long-term care of hypertension conditions. Transdermal drug delivery has provided numerous benefits to the medical community since its inception. These benefits include the drug's non-invasive nature, ex-tended therapeutic effect, reduced adverse effects, greater bioavailability, improved patient com-pliance, and simple termination. This review aims to explore the potential of several antihyperten-sive drugs for transdermal delivery.</p>","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nanotechnology-Enhanced Transdermal Patches for Hypertension: A Review.\",\"authors\":\"Nishant Yadav, Parveen Kumar, Thakur Gurjeet Singh, Sushma Devi\",\"doi\":\"10.2174/0115734021373953250416105243\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Transdermal Drug Delivery System (TDDS) is one of the controlled drug delivery sys-tems whose purpose is to deliver medication through the skin at a predetermined and regulated rate. Nanotechnology has enhanced the skin's absorption of lipophilic, low-molecular-weight med-icines with low-dose efficacy, making transdermal drug delivery systems a viable technique for treating various conditions. TDDS permits greater skin permeation of hydrophilic drugs, and sci-entists are studying macromolecules to improve disease treatment and vaccine development. While additional study is needed to determine nanocarrier safety, this approach could increase the usage of transdermal routes for administering hypertension medicines. As hypertension remains the most prevalent form of cardiovascular illness, we focus on how nanoparticles as skin delivery methods might be used to better treat this global problem. In addition, patients may not be willing to comply with traditional doses due to the greater frequency of drug administration necessary for long-term care of hypertension conditions. Transdermal drug delivery has provided numerous benefits to the medical community since its inception. These benefits include the drug's non-invasive nature, ex-tended therapeutic effect, reduced adverse effects, greater bioavailability, improved patient com-pliance, and simple termination. This review aims to explore the potential of several antihyperten-sive drugs for transdermal delivery.</p>\",\"PeriodicalId\":45941,\"journal\":{\"name\":\"Current Hypertension Reviews\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-04-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Hypertension Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0115734021373953250416105243\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Hypertension Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115734021373953250416105243","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

透皮给药系统(TDDS)是一种受控给药系统,其目的是以预定和调节的速率通过皮肤给药。纳米技术增强了皮肤对亲脂性、低分子量、低剂量药效药物的吸收,使经皮给药系统成为治疗各种疾病的可行技术。TDDS允许亲水性药物更大的皮肤渗透,科学家们正在研究大分子以改善疾病治疗和疫苗开发。虽然需要进一步的研究来确定纳米载体的安全性,但这种方法可以增加经皮途径给药高血压药物的使用。由于高血压仍然是最普遍的心血管疾病,我们关注的是纳米颗粒如何作为皮肤递送方法来更好地治疗这一全球性问题。此外,由于高血压疾病的长期护理需要更频繁的药物管理,患者可能不愿意遵守传统剂量。自成立以来,经皮给药已经为医学界提供了许多好处。这些好处包括药物的非侵入性、延长治疗效果、减少不良反应、更高的生物利用度、提高患者的依从性和简单的终止。本综述旨在探讨几种经皮给药降压药的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Nanotechnology-Enhanced Transdermal Patches for Hypertension: A Review.

Transdermal Drug Delivery System (TDDS) is one of the controlled drug delivery sys-tems whose purpose is to deliver medication through the skin at a predetermined and regulated rate. Nanotechnology has enhanced the skin's absorption of lipophilic, low-molecular-weight med-icines with low-dose efficacy, making transdermal drug delivery systems a viable technique for treating various conditions. TDDS permits greater skin permeation of hydrophilic drugs, and sci-entists are studying macromolecules to improve disease treatment and vaccine development. While additional study is needed to determine nanocarrier safety, this approach could increase the usage of transdermal routes for administering hypertension medicines. As hypertension remains the most prevalent form of cardiovascular illness, we focus on how nanoparticles as skin delivery methods might be used to better treat this global problem. In addition, patients may not be willing to comply with traditional doses due to the greater frequency of drug administration necessary for long-term care of hypertension conditions. Transdermal drug delivery has provided numerous benefits to the medical community since its inception. These benefits include the drug's non-invasive nature, ex-tended therapeutic effect, reduced adverse effects, greater bioavailability, improved patient com-pliance, and simple termination. This review aims to explore the potential of several antihyperten-sive drugs for transdermal delivery.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current Hypertension Reviews
Current Hypertension Reviews PERIPHERAL VASCULAR DISEASE-
CiteScore
4.80
自引率
0.00%
发文量
26
期刊介绍: Current Hypertension Reviews publishes frontier reviews/ mini-reviews, original research articles and guest edited thematic issues on all the latest advances on hypertension and its related areas e.g. nephrology, clinical care, and therapy. The journal’s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all clinicians and researchers in the field of hypertension.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信